ITMI952202A0 - - Google Patents

Info

Publication number
ITMI952202A0
ITMI952202A0 ITMI952202A ITMI952202A ITMI952202A0 IT MI952202 A0 ITMI952202 A0 IT MI952202A0 IT MI952202 A ITMI952202 A IT MI952202A IT MI952202 A ITMI952202 A IT MI952202A IT MI952202 A0 ITMI952202 A0 IT MI952202A0
Authority
IT
Italy
Application number
ITMI952202A
Other languages
Italian (it)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of ITMI952202A0 publication Critical patent/ITMI952202A0/it
Publication of ITMI952202A1 publication Critical patent/ITMI952202A1/it
Application granted granted Critical
Publication of IT1275802B1 publication Critical patent/IT1275802B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
IT95MI002202A 1994-11-03 1995-10-25 Composizione di interferone IT1275802B1 (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33370294A 1994-11-03 1994-11-03

Publications (3)

Publication Number Publication Date
ITMI952202A0 true ITMI952202A0 (enrdf_load_stackoverflow) 1995-10-25
ITMI952202A1 ITMI952202A1 (it) 1997-04-25
IT1275802B1 IT1275802B1 (it) 1997-10-17

Family

ID=23303915

Family Applications (1)

Application Number Title Priority Date Filing Date
IT95MI002202A IT1275802B1 (it) 1994-11-03 1995-10-25 Composizione di interferone

Country Status (4)

Country Link
JP (1) JPH08208510A (enrdf_load_stackoverflow)
DE (1) DE19540669A1 (enrdf_load_stackoverflow)
FR (1) FR2726470B1 (enrdf_load_stackoverflow)
IT (1) IT1275802B1 (enrdf_load_stackoverflow)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9516268D0 (en) * 1995-08-08 1995-10-11 Danbiosyst Uk Compositiion for enhanced uptake of polar drugs from the colon
JP2002265383A (ja) * 2001-03-14 2002-09-18 Mitsubishi Pharma Corp インターフェロンα注射用液状製剤
ES2439738T3 (es) 2001-04-18 2014-01-24 Prometic Biosciences Inc. Ácidos grasos de longitud de cadena media, glicéridos y análogos como factores de supervivencia y activación de neutrófilos
AR043120A1 (es) 2003-02-07 2005-07-20 Prometic Biosciences Inc Acidos grasos de longitud de cadena mediana, gliceridos y analogos como estimuladores de la produccion de progenitores de eritrocitos

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5183746A (en) * 1986-10-27 1993-02-02 Schering Aktiengesellschaft Formulation processes for pharmaceutical compositions of recombinant β-
ZA898331B (en) * 1988-11-22 1990-07-25 Hoffmann La Roche Pharmaceutical compositions
DE3919982A1 (de) * 1989-06-19 1990-12-20 Liedtke Pharmed Gmbh Orale lipidarzneiform
NL9101176A (nl) * 1991-07-05 1993-02-01 Stork Brabant Bv Zeefdrukinrichting met continue rapportering van roterende sjablonen.
US5206219A (en) * 1991-11-25 1993-04-27 Applied Analytical Industries, Inc. Oral compositions of proteinaceous medicaments
JP3418423B2 (ja) * 1993-03-03 2003-06-23 久光製薬株式会社 経粘膜投与用薬剤組成物

Also Published As

Publication number Publication date
IT1275802B1 (it) 1997-10-17
FR2726470A1 (fr) 1996-05-10
FR2726470B1 (fr) 1999-02-26
JPH08208510A (ja) 1996-08-13
ITMI952202A1 (it) 1997-04-25
DE19540669A1 (de) 1996-05-09

Similar Documents

Publication Publication Date Title
DK0677466T3 (enrdf_load_stackoverflow)
EP0669395A3 (enrdf_load_stackoverflow)
FR2728363B1 (enrdf_load_stackoverflow)
DE69535748D1 (enrdf_load_stackoverflow)
EP0667627A3 (enrdf_load_stackoverflow)
FR2717315B1 (enrdf_load_stackoverflow)
ECSDI940213S (enrdf_load_stackoverflow)
ECSDI940198S (enrdf_load_stackoverflow)
ECSDI940192S (enrdf_load_stackoverflow)
ECSDI940190S (enrdf_load_stackoverflow)
ECSDI940185S (enrdf_load_stackoverflow)
ECSDI940184S (enrdf_load_stackoverflow)
ECSDI940182S (enrdf_load_stackoverflow)
ECSDI940183S (enrdf_load_stackoverflow)
ECSMU940035U (enrdf_load_stackoverflow)
BRPI9401073A2 (enrdf_load_stackoverflow)
DK40195A (enrdf_load_stackoverflow)
ECSDI940180S (enrdf_load_stackoverflow)
CN3029140S (enrdf_load_stackoverflow)
EP0666636A3 (enrdf_load_stackoverflow)
CN3027523S (enrdf_load_stackoverflow)
CN3027481S (enrdf_load_stackoverflow)
CN3027196S (enrdf_load_stackoverflow)
CN3026487S (enrdf_load_stackoverflow)
CN3025747S (enrdf_load_stackoverflow)

Legal Events

Date Code Title Description
0001 Granted